ICLR

NASD ICON Plc
Sep 28, 2026 · 9:25 PM ET EOD Market Closed

$175.57 ↑ +0.00 (+0.00%) Trading Up from the previous close of $175.57, $0.30 below the day’s high of $175.87

YTD change
-3.65%
vs 20-day SMA
+5.34%
vs 200-day SMA
+19.53%

Price ranges

Previous day
$170.44 $174.92
open $173.80 close $172.33
-$1.47 (-0.85%)
Today
$169.38 $175.87
open $171.13 now $175.57
+$4.44 (+2.59%)
Past week
$163.16 $175.00
from $164.11 now $175.57
+$11.46 (+6.98%)
Past month
$156.70 $177.50
from $169.72 now $175.57
+$5.85 (+3.45%)
This year
$66.57 $203.91
from $182.22 now $175.57
-$6.65 (-3.65%)

Price & Performance

+70.47 (+67.05%) / 6M

$95.92$126.11$156.30$186.49Mar 30Jun 29Sep 28

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Very Good
  • The stock is 49.5% away from all-time highs of $347.72
  • ICLR is down 4% since the beginning of the year
  • ICLR is up 7% over the past 12 months
  • ICLR is up 3% over the past 1 month
  • 3% of all ICLR investors are betting against ICLR

ICLR reads very good: price sits above both the 20- and 200-day averages, the 12-month move is +7.4%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable Yes
EPS $2.56
Earnings momentum +4.0% Quarterly EPS growth
Quarterly change +4.0%

Valuation

P/E ratio 181.15
Enterprise value $15.9B
Beta 1.10

Balance sheet & scale

Income$28.0K
Revenue$8.1B
Cash$928.4M
Debt$3.5M
Income / Debt 0.01×

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Professional, Scientific, and Technical Services
Industry Group Scientific Research and Development Services
Market cap $13.5B

ICON plc engages in the provision of outsourced development services to the pharmaceutical, biotechnology, and medical device industries. The firm specializes in the development, management, and analysis of programs that support clinical development. It operates through the following geographical segments: Ireland, Rest of Europe, U.S., and Rest of World. The company was founded by John Climax and Ronan Lambe in June 1990 and is headquartered in Dublin, Ireland.

Competitor comparison

TickerCompany PriceChange
REGN Regeneron Pharmaceuticals, Inc. $752.25 -4.54%
IQV IQVIA Holdings Inc $270.97 +0.22%
CRL Charles River Laboratories International, Inc. $294.59 +0.60%
MDGL Madrigal Pharmaceuticals, Inc. $517.04 +0.09%
IT Gartner, Inc. $185.73 -1.15%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.